R&D Advantage Report
–
April 1, 2020
Building on its long history of measuring R&D performance, KMR creates this new flagship report built from its own proprietary research and methods to provide senior management at companies of all sizes with access to key performance indicators from productivity to value in BioPharma R&D.
Sponsors Only
